MENU
+Compare
DYN
Stock ticker: NASDAQ
AS OF
May 20 closing price
Price
$12.34
Change
+$0.68 (+5.83%)
Capitalization
1.4B

DYN Dyne Therapeutics Forecast, Technical & Fundamental Analysis

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases... Show more

DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for DYN with price predictions
May 19, 2025

DYN in upward trend: 10-day moving average broke above 50-day moving average on May 02, 2025

The 10-day moving average for DYN crossed bullishly above the 50-day moving average on May 02, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for DYN just turned positive on April 17, 2025. Looking at past instances where DYN's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

DYN moved above its 50-day moving average on May 08, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DYN advanced for three days, in of 251 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 204 cases where DYN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for DYN moved out of overbought territory on May 05, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 55 cases where DYN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on May 14, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on DYN as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DYN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DYN broke above its upper Bollinger Band on April 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.097) is normal, around the industry mean (16.212). P/E Ratio (0.000) is within average values for comparable stocks, (60.468). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.177). Dividend Yield (0.000) settles around the average of (0.023) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (281.268).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DYN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DYN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

DYN is expected to report earnings to fall 10.42% to -94 cents per share on July 31

Dyne Therapeutics DYN Stock Earnings Reports
Q2'25
Est.
$-0.94
Q1'25
Missed
by $0.20
Q4'24
Beat
by $0.06
Q3'24
Missed
by $0.25
Q2'24
Beat
by $0.02
The last earnings report on May 08 showed earnings per share of -104 cents, missing the estimate of -85 cents. With 1.10M shares outstanding, the current market capitalization sits at 1.40B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Electric Utilities
Address
1560 Trapelo Road
Phone
+1 781 786-8230
Employees
141
Web
https://www.dyne-tx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME28.510.62
+2.22%
GameStop Corp
BTC.X106791.0860001184.914100
+1.12%
Bitcoin cryptocurrency
TSLA343.821.73
+0.51%
Tesla
SPY592.85-2.00
-0.34%
SPDR® S&P 500® ETF
AAPL206.86-1.92
-0.92%
Apple

DYN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with CRNX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+5.83%
CRNX - DYN
53%
Loosely correlated
+1.36%
RNA - DYN
51%
Loosely correlated
+4.70%
ERAS - DYN
49%
Loosely correlated
+4.07%
RVMD - DYN
49%
Loosely correlated
+1.35%
APGE - DYN
49%
Loosely correlated
+1.08%
More